English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

PurPose: Treatment of post-operative pain after breast reconstruction remains a significant challenge for plastic surgeons. Liposomal bupivacaine (LB, Exparel Pacira Pharmaceuticals, Inc., Parsippany, NJ) has been proven to effectively relieve pain in the immediate postoperative period. The purpose of our study is to explore the effects of intraoperatively delivered LB on postoperative narcotic use in women undergoing autologous and implant-based breast reconstruction.

plastic and reconstructive surgery. global open

Abstract: Liposomal Bupivacaine Reduces Postoperative Narcotic Use in Patients Undergoing Abdominal-Based Autologous and Implant-Based Breast Reconstruction